Boston University School of Law

Personalized Medicine and Intellectual Property Conference

Summary

Personalized Medicine and Intellectual Property Conference

Description

In the wake of recent U.S. Supreme Court rulings that found that the human gene BRCA (which produces tumor suppression proteins) and a diagnostic test for Vitamin B deficiency were not inventions that could be patented, BU Law is hosting this conference to examine the potential impact of these rulings on medical research by private companies. The Kauffman Foundation is funding the conference, which will bring together legal, business and economic experts to weigh in on the after-effects of the Prometheus and Mryiad rulings.

The event is open to the public. More information to come.

Starts

9:00am on Monday, August 25th 2014

End Time

5:00pm

Location

Redstone Building, Room 101

URL

Topics

Alumni, Faculty/Staff, BU Law Home, J.D. Central, LL.M. Central